"Comparing Ozempic and Wegovy: A New Approach to Weight-Loss Drugs"

Many patients struggle with medication adherence, leading to preventable medical costs and deaths, but the new obesity drugs Wegovy and Zepbound are showing promise in overcoming this issue. Doctors have observed that patients are faithfully taking these drugs, which have been effective in helping people lose weight and keep it off. While some patients may initially hesitate to start the medication, those who do begin are reportedly continuing with it, indicating a potential breakthrough in addressing medication nonadherence in the treatment of obesity.